Yes if:
One specific pathogen (viral, fungal, or bacterial) causes 200,000+ U.S. hospitalizations
Hospitalizations occur within Jan 15 - Apr 15, 2026
Confirmed by CDC or state health department data
NO if:
Threshold not met by April 15, 2026
No single pathogen reaches 200,000 individually
No official data avail
Data Sources: CDC Hospital Respiratory Data, FluView, COVID Data Tracker, MMWR, or state health departments
Resolution Date: April 30, 2026 (allows for data lag)
What Counts: Any single viral, fungal, or bacterial pathogen causing 200K+ hospitalizations (includes the flu, new COVID variants, novel diseases, etc.)
What Doesn't Count: Multiple diseases combined, non-infectious causes, or aggregate totals without single pathogen attribution
Edge Cases
Normal flu surge? YES if it reaches 200K+ hospitalizations
COVID variant? YES if that variant causes 200K+ new hospitalizations
Disease from abroad? YES if it causes 200K+ U.S. hospitalizations
Two diseases at 110K each? NO - must be single pathogen
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ52 | |
| 2 | Ṁ25 | |
| 3 | Ṁ13 | |
| 4 | Ṁ7 | |
| 5 | Ṁ5 |
CDC data show that no single pathogen reached 200,000 U.S. hospitalizations between Jan 15 and Apr 15, 2026. Influenza, the only plausible candidate, had already accumulated roughly 370,000 total hospitalizations for the entire season (since Oct 1, 2025) by early April 2026, implying only about 120k–190k occurred during the Jan–Apr window, which is below the threshold. In addition, CDC surveillance and forecasts show that by early April (latest reported data through April 4–11, 2026), weekly influenza hospital admissions had already declined to low thousands and were continuing to fall, with forecasts of only ~130–2,700 per week through late April, making it impossible to add the remaining tens of thousands needed before April 15. Other pathogens (COVID-19, RSV) were at substantially lower hospitalization levels.